Category English

Imperfect Compromise Seen In India Data Exclusivity Report

By Tatum Anderson for Intellectual Property Watch
When the Indian government published its report recently on yet another pharmaceutical patent-related issue predicted to split the industry, the Indian newspapers were divided as to whether brand name producers, generics producers or public health advocates had won.

The reason for the confusion is that the report is an exercise in appeasement, said Shamnad Basheer, a law professor at George Washington University Law School, and expert on this latest controversial subject, called data exclusivity, which is the rights drugs producers have over the data used to obtain marketing approval in a country.

WIPO Development Agenda Meeting Starts Directly With Proposals

By William New with Tove Iren S. Gerhardsen A weeklong meeting on proposals to change the World Intellectual Property Organization mandate or practices toward development began almost immediately with a focus on substantive proposals, according to participating officials. But the…